David Shaw’s Axonics, Inc. Common Stock AXNX Stock Holding History

David Shaw’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,325	Closed	-$207K	–	4837
2023 Q4	$207K	Sell	3,325 -568	-15%	-$31.8K	﹤0.01%	3874
2023 Q3	$218K	Sell	3,893 -36,598	-90%	-$2.06M	﹤0.01%	3731
2023 Q2	$2.04M	Sell	40,491 -160,148	-80%	-$8.52M	﹤0.01%	2607
2023 Q1	$10.9M	Buy	200,639 +16,780	+9%	+$980K	0.01%	1293
2022 Q4	$11.5M	Buy	183,859 +86,788	+89%	+$5.76M	0.01%	1325
2022 Q3	$6.84M	Buy	+97,071	New	+$6.7M	0.01%	1745
2021 Q4	–	Sell	-34,627	Closed	-$2.25M	–	5785
2021 Q3	$2.25M	Buy	+34,627	New	+$2.36M	﹤0.01%	2932

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

David Shaw's AXNX Position: Q1 2024 in Review

David Shaw sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 3,325 shares — an estimated $207K sold.

David Shaw first reported a position in AXNX in Q3 2021 and held it in 7 quarters. The position peaked at $11.5M in Q4 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

David Shaw reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
David Shaw sold 3,325 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $207K.
David Shaw first reported a position in Axonics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
David Shaw's Axonics, Inc. Common Stock position peaked at $11.5M in Q4 2022.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.